المؤلفون: Chiara Elena, Eros Di Bona, Elisa Diral, Enrico Gottardi, Philipp le Coutre, Alessandra Pirola, Micaela Bergamaschi, Dong-Wook Kim, Jessica Petiti, Alessandra Iurlo, Maria Luisa Bonanomi, Rocco Piazza, Carmen Fava, Patrizia Crivori, Fabio Stagno, Carlo Gambacorti-Passerini, Sarit Assouline

المساهمون: Diral, E, Le Coutre, P, Gottardi, E, Elena, C, Bergamaschi, M, Assouline, S, Di Bona, E, Petiti, J, Stagno, F, Iurlo, A, Kim, D, Pirola, A, Bonanomi, M, Crivori, P, Piazza, R, Fava, C, Gambacorti-Passerini, C

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Immunology, Tumor burden, Leukemia Myelogenous Chronic, BCR-ABL Positive, polymerase chain reaction, neoplasms, reverse transcriptase polymerase chain reaction, imatinib mesylate, protein-tyrosine kinase inhibitor, disease remission, Positive control, Biochemistry, 03 medical and health sciences, 0302 clinical medicine, MED/15 - MALATTIE DEL SANGUE, hemic and lymphatic diseases, Internal medicine, medicine, Digital polymerase chain reaction, business.industry, Myeloid leukemia, Imatinib, Cell Biology, Hematology, Discontinuation, 030104 developmental biology, Imatinib mesylate, Functional status, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57a9c99d29ecda6ec4795d5c257f63e8Test
http://hdl.handle.net/10281/259549Test

المؤلفون: Bryone J. Kuss, Ian W. Flinn, Paolo Ghia, Juthamas Sukbuntherng, Ahmed Salem, John N. Allan, Paul M. Barr, Ryan Jacobs, Cathy Zhou, Alessandra Tedeschi, Xavier Badoux, Constantine S. Tam, Karl Eckert, Danelle F. James, Tanya Siddiqi, William G. Wierda, Stephen Opat, Thomas J. Kipps, Joi Ninomoto, Kristin Russell

المساهمون: Tam, C. S., Siddiqi, T., Allan, J. N., Kipps, T. J., Flinn, I. W., Kuss, B. J., Opat, S., Barr, P. M., Tedeschi, A., Jacobs, R., Badoux, X. C., Ghia, P., Sukbuntherng, J., Salem, A. H., Russell, K., Eckert, K., Zhou, C., Ninomoto, J., James, D. F., Wierda, W. G.

مصطلحات موضوعية: 0301 basic medicine, Immunology, Disease progression, Stock options, Cell Biology, Hematology, Biochemistry, Small cell lymphoma, Lymphocytic lymphoma, Management, First line treatment, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Disease remission, Honorarium, Business, Protein p53, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a44e9f5ae70f78fa9be8e5498cd2cacfTest

مصطلحات الفهرس: Leukemia Myelogenous Chronic, BCR-ABL Positive, polymerase chain reaction, neoplasms, reverse transcriptase polymerase chain reaction, imatinib mesylate, protein-tyrosine kinase inhibitor, disease remission, MED/15 - MALATTIE DEL SANGUE, info:eu-repo/semantics/article

URL: http://hdl.handle.net/10281/259549Test
info:eu-repo/semantics/altIdentifier/pmid/31723989
info:eu-repo/semantics/altIdentifier/wos/WOS:000518218500628
volume:134
issue:1
firstpage:29
journal:BLOOD